| Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions E Russell, G Koren, M Rieder, S Van Uum Psychoneuroendocrinology 37 (5), 589-601, 2012 | 1386 | 2012 |
| Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study NA Kulin, A Pastuszak, SR Sage, B Schick-Boschetto, G Spivey, ... Jama 279 (8), 609-610, 1998 | 641 | 1998 |
| Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline A Taddio, M Appleton, R Bortolussi, C Chambers, V Dubey, S Halperin, ... Cmaj 182 (18), E843-E855, 2010 | 563 | 2010 |
| Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester SJ Jacobson, L Ceolin, P Kaur, A Pastuszak, T Einarson, G Koren, ... The Lancet 339 (8792), 530-533, 1992 | 491 | 1992 |
| An assessment of cortisol analysis in hair and its clinical applications R Gow, S Thomson, M Rieder, S Van Uum, G Koren Forensic science international 196 (1-3), 32-37, 2010 | 483 | 2010 |
| Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children H Visscher, CJD Ross, SR Rassekh, A Barhdadi, MP Dubé, H Al-Saloos, ... Journal of clinical oncology 30 (13), 1422-1428, 2012 | 477 | 2012 |
| More codeine fatalities after tonsillectomy in North American children LE Kelly, M Rieder, J van den Anker, B Malkin, C Ross, MN Neely, ... Pediatrics 129 (5), e1343-e1347, 2012 | 460 | 2012 |
| Regulation of cytokine and cytokine receptor expression by glucocorticoids WY Almawi, HN Beyhum, AA Rahme, MJ Rieder Journal of leukocyte biology 60 (5), 563-572, 1996 | 431 | 1996 |
| Reducing pain during vaccine injections: clinical practice guideline A Taddio, CM McMurtry, V Shah, RP Riddell, CT Chambers, M Noel, ... Cmaj 187 (13), 975-982, 2015 | 423 | 2015 |
| Inadequate pain management during routine childhood immunizations: the nerve of it A Taddio, CT Chambers, SA Halperin, M Ipp, D Lockett, MJ Rieder, ... Clinical therapeutics 31, S152-S167, 2009 | 397 | 2009 |
| Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy CJD Ross, H Katzov-Eckert, MP Dubé, B Brooks, SR Rassekh, ... Nature genetics 41 (12), 1345-1349, 2009 | 395 | 2009 |
| Hair cortisol analysis: An update on methodological considerations and clinical applications MJE Greff, JM Levine, AM Abuzgaia, AA Elzagallaai, MJ Rieder, ... Clinical biochemistry 63, 1-9, 2019 | 329 | 2019 |
| A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer F Aminkeng, AP Bhavsar, H Visscher, SR Rassekh, Y Li, JW Lee, ... Nature genetics 47 (9), 1079-1084, 2015 | 315 | 2015 |
| Hair analysis provides a historical record of cortisol levels in Cushing's syndrome S Thomson, G Koren, LA Fraser, M Rieder, TC Friedman, SHM Van Uum Experimental and Clinical Endocrinology & Diabetes 118 (02), 133-138, 2010 | 293 | 2010 |
| Diagnosis of sulfonamide hypersensitivity reactions by in-vitro" rechallenge" with hydroxylamine metabolites MJ Rieder, J Uetrecht, NH Shear, M Cannon, M Miller, SP Spielberg Annals of internal medicine 110 (4), 286-289, 1989 | 281 | 1989 |
| Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity F Aminkeng, CJD Ross, SR Rassekh, S Hwang, MJ Rieder, AP Bhavsar, ... British journal of clinical pharmacology 82 (3), 683-695, 2016 | 264 | 2016 |
| Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions MJ Rieder, NH Shear, A Kanee, BK Tang, SP Spielberg Clinical Pharmacology & Therapeutics 49 (1), 13-17, 1991 | 258 | 1991 |
| The detection of cortisol in human sweat: implications for measurement of cortisol in hair E Russell, G Koren, M Rieder, SHM Van Uum Therapeutic drug monitoring 36 (1), 30-34, 2014 | 242 | 2014 |
| Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline‐induced cardiotoxicity in children H Visscher, CJD Ross, SR Rassekh, GSS Sandor, HN Caron, ... Pediatric blood & cancer 60 (8), 1375-1381, 2013 | 242 | 2013 |
| Recommendations for HLA‐B* 15: 02 and HLA‐A* 31: 01 genetic testing to reduce the risk of carbamazepine‐induced hypersensitivity reactions U Amstutz, NH Shear, MJ Rieder, S Hwang, V Fung, H Nakamura, ... Epilepsia 55 (4), 496-506, 2014 | 240 | 2014 |
